Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $130.58 USD
Change Today +0.71 / 0.55%
Volume 846.7K
WAT On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 4:05 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

waters corp (WAT) Key Developments

Waters Corporation Announces Executive Changes

Waters Corporation announced that Christopher J O'Connell has been appointed as its new President, Chief Executive Officer (CEO) and member of its Board of Directors, effective in September 2015. Chris joins Waters from Medtronic plc. Over his 21 years at Medtronic, Chris O'Connell held a variety of leadership positions, most recently as president of the Restorative Therapies Group. He provided overall strategic direction and operational management of the group's five divisions, as well as led the integration of the group's activities within the overall strategy of the corporation. Retiring chief executive officer, Douglas A Berthiaume will continue in his role as chairman of Waters' board of directors.

Waters Corporation expected to report Q2 2015 results on July 27, 2015. This event was calculated by Capital IQ (Created on July 9, 2015).

Waters Corporation expected to report Q2 2015 results on July 27, 2015. This event was calculated by Capital IQ (Created on July 9, 2015).

Waters Corporation, Q2 2015 Earnings Call, Jul 28, 2015

Waters Corporation, Q2 2015 Earnings Call, Jul 28, 2015

Waters Corporation Announces Management Changes

On June 25, 2015, Waters Corporation announced that Christopher J. O'Connell has been hired to serve as its President and Chief Executive Officer and as a member of its Board of Directors, commencing on September 8, 2015. Previously, Mr. O'Connell served as Executive Vice President and Group President, Restorative Therapies Group, of Medtronic plc (formerly Medtronic Inc.) since August, 2009. Retiring CEO, Douglas A. Berthiaume will continue in his role as chairman of Waters’ Board of Directors.

Waters Corporation Introduces the New ACQUITY Arc System

Waters Corporation announced that it has introduced the Waters ACQUITY Arc System, a quaternary liquid chromatograph that gives analytical laboratories running established LC methods a clear choice for replicating or improving their separations performance. With this new addition to the ACQUITY product line, the new ACQUITY Arc System is specifically engineered to respond to the needs of analytical scientists for a single LC platform that can enable them to efficiently transfer, adjust or improve their methods regardless of the LC platform on which they were developed. Waters intends to begin shipping the ACQUITY Arc system to customers at the end of June 2015. Waters ACQUITYArc System is a quaternary liquid chromatograph and a new addition to the ACQUITY product line. The new ACQUITY Arc System is specifically engineered to respond to the needs of analytical scientists for a single LC platform that can enable them to efficiently transfer, adjust or improve their analytical methods regardless of the LC platform on which they were developed. In addition to replicating established HPLC assays without altering the gradient table, the ACQUITY Arc System can enable improved chromatographic performance of methods by leveraging 2.5 - 2.7 micron particle column technologies, as well as support previously developed applications on 3 - 5 micron HPLC columns. Waters is offering a full complement of LC detectors for the ACQUITY Arc System, including photodiode array, UV/Vis, fluorescence, refractive index and evaporative light scattering. The system is also fully compatible with Waters mass detector, the ACQUITY QDa. In addition, the ACQUITY Arc System features novel Auto-Blend Plus Technology that enables the operator to program directly % organic and % pH gradients to significantly reduce human error and the manual labor associated with preparing buffered mobile phases. The ACQUITY Arc System is controlled through Waters informatics packages of Empower 2 or Empower 3 software.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WAT:US $130.58 USD +0.71

WAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $84.82 USD +1.05
Mettler-Toledo International Inc $334.99 USD +5.42
PerkinElmer Inc $50.70 USD +0.27
Sigma-Aldrich Corp $139.64 USD +0.21
WR Grace & Co $97.88 USD +0.60
View Industry Companies
 

Industry Analysis

WAT

Industry Average

Valuation WAT Industry Range
Price/Earnings 24.0x
Price/Sales 5.3x
Price/Book 5.8x
Price/Cash Flow 23.0x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WATERS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.